Winner Medical Company issued an announcement stating that the company intends to use its own funds of RMB 727.54 million to acquire a total of 55% of its shares in Longterm Medical from Mr. Wu Kangping, Ms. Huang Lepei and Mr. Wu Di. Longterm Medical’s main business is high-end wound dressings (including silicone foam, hydrocolloid, silicone gel, hydrogel, film application and stoma products) research and development, production and sales.
Longterm Medical has been established for 10 years, and Winner Medical has a history of 31 years. It has ranked among the top three in China’s medical dressing exports for many years, and its business covers more than 110 countries. Both parties are one of the earliest domestic companies that develop, produce and export high-end wound dressings, and have a long-term and stable accumulation of high-quality customers in this field. The two parties will form a leading effect through the synergy of sales and product research and development, and are expected to gain a larger market share and higher revenue growth.
As a company that has reaped dividends during the epidemic, Winner Medical urgently needs to find the next growth point. The acquisition of Longterm Medical may be its attempt to stabilize its position in the industry and find its next development direction.